UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection

Antiviral research, 2024-09, Vol.229, p.105960, Article 105960

2024

Volltextzugriff (PDF)

Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice

Virology (New York, N.Y.), 2024-10, Vol.598, p.110194, Article 110194

2024

Volltextzugriff (PDF)

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

Immunity (Cambridge, Mass.), 2019-09, Vol.51 (3), p.429-442

2019

Volltextzugriff (PDF)

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Vaccine, 2016-09, Vol.34 (42), p.5114-5124

2016

Volltextzugriff (PDF)

Immunology of bovine respiratory syncytial virus in calves

Molecular immunology, 2015-07, Vol.66 (1), p.48-56

2015

Volltextzugriff (PDF)

Novel antigens for RSV vaccines

Current opinion in immunology, 2015-08, Vol.35, p.30-38

2015

Volltextzugriff (PDF)

A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice

Vaccine, 2017-02, Vol.35 (5), p.757-766

2017

Volltextzugriff (PDF)

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

Virology (New York, N.Y.), 2016-07, Vol.494, p.215-224

2016

Volltextzugriff (PDF)

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

Vaccine, 2020-01, Vol.38 (2), p.251-257

2020

Volltextzugriff (PDF)

Improved RSV preF protein vaccine quality and stability by elucidation of supercooling-induced aggregation phenomena

European journal of pharmaceutics and biopharmaceutics, 2024-10, Vol.203, p.114457, Article 114457

2024

Volltextzugriff (PDF)

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Vaccine, 2024-05, Vol.42 (15), p.3474-3485

2024

Volltextzugriff (PDF)

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Immunity (Cambridge, Mass.), 2021-04, Vol.54 (4), p.769-780.e6

2021

Volltextzugriff (PDF)

Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants

Vaccine, 2024-11, Vol.42 (25), p.126119, Article 126119

2024

Volltextzugriff (PDF)

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants

Vaccine, 2020-01, Vol.38 (2), p.101-106

2020

Volltextzugriff (PDF)

Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25–26 April 2016

Vaccine, 2019-11, Vol.37 (50), p.7355-7362

2019

Volltextzugriff (PDF)

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Virology (New York, N.Y.), 2019-08, Vol.534, p.1-13

2019

Volltextzugriff (PDF)

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Antiviral research, 2019-08, Vol.168, p.9-17

2019

Volltextzugriff (PDF)

Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease

Virology (New York, N.Y.), 2015-02, Vol.476, p.217-225

2015

Volltextzugriff (PDF)

Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles

Vaccine, 2012-07, Vol.30 (35), p.5206-5214

2012

Volltextzugriff (PDF)

Animal models of respiratory syncytial virus infection

Vaccine, 2017-01, Vol.35 (3), p.469-480

Taylor, Geraldine

2017

Volltextzugriff (PDF)

Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy

Vaccine, 2015-10, Vol.33 (41), p.5371-5379

2015

Volltextzugriff (PDF)

A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus

Virology (New York, N.Y.), 2016-12, Vol.499, p.288-297

2016

Volltextzugriff (PDF)

Potential impact of a maternal vaccine for RSV: A mathematical modelling study

Vaccine, 2017-10, Vol.35 (45), p.6172-6179

2017

Volltextzugriff (PDF)

Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota

Journal of allergy and clinical immunology, 2017-10, Vol.140 (4), p.1068-1078.e6

2017

Volltextzugriff (PDF)

Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats

Vaccine, 2013-04, Vol.31 (17), p.2169-2176

2013

Volltextzugriff (PDF)

1 – 25 von 1.246

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Immunological Methods

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.222)
Mit Volltextzugriff
(1.245)

Publikationsform

Artikel
(1.246)

Sprache

Englisch
(1.245)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.164)
Life Sciences & Biomedicine
(1.162)
Respiratory Syncytial Virus
(879)
Humans
(775)
Immunology
(729)
Animals
(594)
Female
(451)
Biological And Medical Sciences
(441)
Virology
(419)
Medicine, Research & Experimental
(396)
Research & Experimental Medicine
(396)
Respiratory Syncytial Viruses - Immunology
(362)
Respiratory Syncytial Virus Infections - Immunology
(349)
Fundamental And Applied Biological Sciences. Psychology
(333)
Vaccines
(329)
Microbiology
(317)
Infant
(295)
Viruses
(294)
Allergy And Immunology
(287)
Mice
(281)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(1.229)
Elsevier ScienceDirect Journals Complete
(1.222)
MEDLINE
(1.138)
IngentaConnect Journals
(373)
Journals@Ovid Full Text
(306)
EZB Electronic Journals Library
(262)
Single Journals
(227)
EBSCOhost Business Source Ultimate
(19)
Psychology and Behavioral Sciences Collection
(19)
Wiley Online Library
(17)
Wiley Online Library Full Collection 2018
(17)
Springer Book Series
(7)
Oxford Journals
(3)
Oxford Journals 2020 Medicine
(3)

9 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Cold-adapted influenza vaccine carrying three repeats of a respiratory syncytial virus (RSV) fusion glycoprotein epitope site protects BALB/c mice and cotton rats against RSV infection

Mucosal delivery of a prefusogenic-F, glycoprotein, and matrix proteins-based virus-like particle respiratory syncytial virus vaccine induces protective immunity as evidenced by challenge studies in mice

Immunological Lessons from Respiratory Syncytial Virus Vaccine Development

Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity

Immunology of bovine respiratory syncytial virus in calves

Novel antigens for RSV vaccines

A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice

Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease

Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants

Improved RSV preF protein vaccine quality and stability by elucidation of supercooling-induced aggregation phenomena

VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice

Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responses

Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants

Summary of the Vaccines and Related Biological Products Advisory Committee meeting held to consider evaluation of vaccine candidates for the prevention of respiratory syncytial virus disease in RSV-naïve infants

Meeting report: WHO consultation on Respiratory Syncytial Virus (RSV) vaccine development, Geneva, 25–26 April 2016

A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease

Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles

Animal models of respiratory syncytial virus infection

Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy

A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus

Potential impact of a maternal vaccine for RSV: A mathematical modelling study

Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota

Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton rats

Aktive Filter

Suchergebnisse filtern